Acetylsalisylsyre Actavis 75 mg Norge - norsk - Statens legemiddelverk

acetylsalisylsyre actavis 75 mg

actavis group ptc ehf - acetylsalisylsyre - enterotablett - 75 mg

Acetylsalisylsyre Actavis 160 mg Norge - norsk - Statens legemiddelverk

acetylsalisylsyre actavis 160 mg

actavis group ptc ehf - acetylsalisylsyre - enterotablett - 160 mg

Sertralin Hexal 100 mg Norge - norsk - Statens legemiddelverk

sertralin hexal 100 mg

hexal a/s - sertralinhydroklorid - tablett, filmdrasjert - 100 mg

Sertralin Hexal 50 mg Norge - norsk - Statens legemiddelverk

sertralin hexal 50 mg

hexal a/s - sertralinhydroklorid - tablett, filmdrasjert - 50 mg

Acetylsalisylsyre Norfri 500 mg Norge - norsk - Statens legemiddelverk

acetylsalisylsyre norfri 500 mg

evolan pharma ab - acetylsalisylsyre - tablett - 500 mg

Clopidogrel / Acetylsalicylic acid Mylan Den europeiske union - norsk - EMA (European Medicines Agency)

clopidogrel / acetylsalicylic acid mylan

mylan pharmaceuticals limited - acetylsalicylic acid, clopidogrel hydrogen sulfate - acute coronary syndrome; myocardial infarction - antithrombotic agents - clopidogrel/acetylsalisylsyre mylan er indikert for sekundær forebygging av atherothrombotic hendelser hos voksne pasienter som allerede tar både klopidogrel og acetylsalisylsyre (asa). clopidogrel/acetylsalisylsyre mylan er en fast dose kombinasjon legemiddel for videreføring av behandling i:ikke-st-segment elevasjon akutt koronar syndrom (ustabil angina eller non-q-bølge myocardial infarction) inkludert pasienter som gjennomgår en stent plassering etter perkutan koronar interventionst segment elevasjon akutte myocardial infarction i medisinsk behandlede pasienter kvalifisert for trombolytisk behandling.

Clopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) Den europeiske union - norsk - EMA (European Medicines Agency)

clopidogrel/acetylsalicylic acid zentiva (previously duocover)

sanofi-aventis groupe - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - antithrombotic agents - akutt koronar syndromemyocardial infarction.

Nordimet Den europeiske union - norsk - EMA (European Medicines Agency)

nordimet

nordic group b.v. - methotrexate - arthritis, psoriatic; psoriasis; arthritis, juvenile rheumatoid; arthritis, rheumatoid - antineoplastiske midler - nordimet is indicated for the treatment of:active rheumatoid arthritis in adult patients,polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate,moderate to severe plaque psoriasis in adults who are candidates for systemic therapy, and severe psoriatic arthritis in adult patients, induction of remission in moderate steroid-dependent crohn's disease in adult patients, in combination with corticosteroids and for maintenance of remission, as monotherapy, in patients who have responded to methotrexate.

Diprasorin 200 mg / 25 mg Norge - norsk - Statens legemiddelverk

diprasorin 200 mg / 25 mg

orion corporation - espoo - dipyridamol / acetylsalisylsyre - kapsel med modifisert frisetting, hard - 200 mg / 25 mg

Methotrexate Cipla 2.5 mg Norge - norsk - Statens legemiddelverk

methotrexate cipla 2.5 mg

cipla europe nv - metotreksat - tablett - 2.5 mg